Biotech IB... top groups/offices?
Trending Content - Investment Banking Forum
Career Resources
WSO Free Modeling Series - Now Open Through
September 30, 2026
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
High Finance Applications
Guaranteed
Get at least one offer GUARANTEED
- 1:1 support
- 92% success rate
- 2,000+ mentor network
- Unlimited Live bootcamps
- AI for resume + LinkedIn
- Networking automation tools
- HireVue simulation tool
- Full course library
- Private Slack community
- 20hrs of mocks
- + much more...
JPM Hong Kong is pretty focused on healthcare. Apart from that, a number of middle market firms in that range in sell-side. From what I remember faintly, Cain Bros SF and Cowen and Company are also leading in healthcare. Haven't heard of a strong rep from Wells Fargo SF.
Thanks! But do they also cover Biotech in HK?
I know Cain's pretty strong in HC, but they do not cover Biotech (yet), only pharma and services...
Dunno about biotech specifically, but if you're narrowing down to specific Biotech coverage, I doubt you'd find many banks doing so. Even if they would, they wouldn't hire a guy rightaway out of undergrad SPECIFICALLY for the biotech group (you'll have to go through the generalist process and yada yada), or you could hedge your bets and luck out too. Best bet is to go for pharma focused groups.
Note, I'm advising coming from the same problems as you. I once focused on just biotech groups and did not get selected in any banks for internships. Ended up going into an engineering intern that summer. Which sucked. Don't want to get into that quagmire.
I've seen biotech in Boston offices for a few banks; Piper, Baird off the top of my head. There are a lot of boutiques out there too (Leerink, JSB, Backbay Life Sciences, etc). If you're really that passionate about biotech, theres a lot of consulting for Biotech out there as well. I dont think there are many big banks with groups specifically covering biotech companies, mostly its just HC groups that cover all verticals.
Agree with this. Boston is great for healthcare opportunities, while SF banks are just too hard to get into, considering everyone's behind tech and HC in Cal. Ideally though, you should be looking at where your school is to maximize chances.
For Piper HC in Mpls is broken up into 3 verticals: medtech, HCIT, biopharm/biotech.
Thought their main biopharma office was NYC though...whats in MPLS?
Pretty confident Baird does not have a IBD office in Boston. Piper's office is like 10 ppl only doing Tech.
They have 2 IBD positions in Boston listed on their website right now.
They most definitely have a life sciences office in Boston.
Would add Cowen and Leerink to the boutique list.
Cantor is actually making a huge push up after they hired Sage Kelly. They just recently started building out the research arm by drawing over some big name analysts and brought over Barclays head of US equities to lead their global equities business unit.
I would def shoot for going there because no doubt orgies and, for the more senior crowd, wifeswaps, will be included in your comp package.
I didn't know about this. When did Cantor become a fuckshow? Thought they became real solemn after 9/11.
In SF, Wells Fargo is strong in biotech -- but I know someone who worked there and was basically a slave.
I've heard of the shit culture at WFC in general (not encouraging of exits, too slow and hierarchial compared to other firms), but not heard of it being a strong biotech shop. Usual names are MS, Laz and JPM, though I may also be wrong/underexposed.
leerink jeffries Cowen are all really good. cantor is doing really well getting exclusive book runner on a lot of deals, but the word on the street is that the VC's are getting upset with Cantor for selling bought deals. A lot of their clients wont be banking with them again.
http://www.roth.com
Roth hc team just left for op. Co
FYI, this is a SF perspective. Can't believe no one mentioned CV... CV has been killing it in biotech the past few years; I would say CV is the current leader (coming from someone heading into a life sciences HC team that's not CV). JPM LAZ and GS (WRA) are strong too.
Also, just to answer your question on whether GS WRA covers biotech--yes they do. Have a friend who worked there this summer.
Eos ex quae quasi voluptatum quis. Quo exercitationem architecto et voluptatem.
Praesentium dolores accusamus molestiae voluptatem aspernatur voluptas. Quas optio voluptas corrupti molestiae dolor sequi alias. Vitae officia ratione autem neque. Cum fugiat recusandae quae aspernatur ut repellendus.
Repudiandae quisquam adipisci est. Magni rem aut unde occaecati labore modi. Tenetur id repellendus officia cum in architecto qui.
Eaque atque consequatur eum id explicabo. Sed voluptatum at ut recusandae consequatur occaecati omnis. Aspernatur quia sapiente blanditiis eum a dignissimos hic. Vel ipsam vero cumque aut magni. Quis expedita ad totam explicabo aut totam fuga.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
In quae et quo. In sunt ut optio eum nihil. Deserunt ab recusandae ut ut. In totam dolorem iusto provident. Itaque eos quia neque tenetur. Dolorem omnis et repellendus recusandae et.
Itaque ut consequuntur qui libero rem nihil et. Libero a dicta esse facilis cum recusandae ut amet. Atque et quia non quaerat id optio. Placeat adipisci ipsa et.